Ciprofloxacin
Product Images NDC 10544-943

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Ciprofloxacin (NDC 10544-943). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Blenheim Pharmacal, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label 500mg 14ct (Label Ciprofloxacin Tabs 500mg Bpi(10544 943 14) Blu(24658 250 05) Rev1)

Label 500mg 14ct (Label Ciprofloxacin Tabs 500mg Bpi(10544 943 14) Blu(24658 250 05) Rev1)
This text is a product description of Ciprofloxacin, a medication in tablet form. It contains information on the dosage, storage instructions, and the manufacturer's details. The lot number and expiration date are also provided for each package. However, some parts of the text are unclear, potentially due to errors.*
FDA Label Image

Ciprofloxacin Chemical Structure (Ciprofloxacin Tablets 1)

FDA Label Image

Table 1 (Ciprofloxacin Tablets 2)

Table 1 (Ciprofloxacin Tablets 2)
This is a table with susceptibility test interpretive criteria for Ciprofloxacin, showing the minimum inhibitory concentration (MIC) values for various bacterial strains. The table includes Enterobacteriaceae, Enterococcus faecalis, Staphylococcus aureus, Pseudomonas aeruginosa, Haemophilus influenzae, Salmonella, Streptococcus pneumoniae, Streptococcus pyogenes, and Neisseria gonorrhoeae. There is a note stating that the absence of data on resistant isolates precludes results other than "susceptible" and any isolates with MIC results other than susceptible should be submitted for further testing.*
FDA Label Image

Table2 (Ciprofloxacin Tablets 3)

Table2 (Ciprofloxacin Tablets 3)
This is a table showing the results of quality control for susceptibility testing of Ciprofloxacin on various strains of bacteria including Enterococcus faecalis, Escherichia coli, Haemophilus influenza, Pseudomonas aeruginosa, Staphylococcus aureus, Neisseria gonorrhoeae, and Campylobacter jejuni. The table provides information on the MIC range and zone diameter (in mm) for each strain tested. The testing procedures used for different strains are also mentioned.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.